| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed28726de9f916f355f8adc331e736b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0085 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
2004-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbff8d47afab89b9d3f3db89e1c792bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_381bee41744705532e6d93f392746441 |
| publicationDate |
2006-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1662879-A2 |
| titleOfInvention |
Indirect delivery of growth factors into the central nervous system |
| abstract |
A method of delivering a therapeutic to the central nervous system comprising admininistering a therapeutic intramuscularly in to muscle innervated by cranial and/or spinal nerves,and transporting the therapeutic peripherally through the nerves into the CNS. |
| priorityDate |
2003-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |